Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TLR4–KSRP–let-7 microRNA processing pathway is a sophisticated regulatory circuit in immune cells that controls the magnitude and duration of the inflammatory response [1]. Toll-like receptor 4 (TLR4) serves as the primary sensor for bacterial lipopolysaccharides, triggering downstream signaling upon activation. A key component of this response is the KH-type splicing regulatory protein (KSRP), an RNA-binding protein that facilitates the maturation of the let-7 microRNA family [1, 2]. KSRP binds specifically to the terminal loops of let-7 precursors, enhancing their processing by the Drosha and Dicer complexes. Once mature, let-7 microRNAs act as post-transcriptional repressors of several pro-inflammatory cytokines and the TLR4 receptor itself [3]. This interaction creates a negative feedback loop essential for preventing excessive inflammation and promoting the resolution of the immune response. Dysfunction in this axis is linked to various pathologies, including sepsis, chronic inflammatory disorders, and oncogenesis. Pharmacological modulation of this pathway, such as through TLR4 inhibitors or microRNA-based therapeutics, represents a promising approach for treating immune-mediated diseases. [1] Trabucchi M, et al. Nature. 2009;459(7249):1010-1014. [2] O'Neill LA, et al. Nat Rev Immunol. 2011;11(3):163-175. [3] Chen XM, et al. J Biol Chem. 2007;282(39):28721-28728.
Modulation of TLR4 signaling and KSRP-mediated microRNA maturation to regulate pro-inflammatory gene expression through post-transcriptional silencing.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 4–KH-type splicing regulatory protein–let-7 microRNA signaling pathway (TLR4–KSRP–let-7 axis).